411 Borel Ave Ste 606
Vium bridges the divide separating Silicon Valley innovation and preclinical drug research, where methodologies, systems, and tools have remained largely unchanged for decades.
5 articles with VIUM
7/30/2018Transition continues as biotech companies continue to adjust their leadership ranks and strengthen the members of their organization representing and overseeing the companies. Here is a look at some of those transitions.
The peer reviewed paper was published in the journal Frontiers in Pharmacology.